Sanofi American Depositary Shares (Each representing one-half of one ordinary share) SNY
$40.62
-1.37%
at last close
Analyst Consensus
- Consensus Rating
- Hold (1 Buy · 4 Hold · 0 Sell)
- Average Price Target
- —
- Implied Upside
- —
- Price Target Range
- —
- Analysts (12 mo)
- 5
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-01-16 | UBSMatthew Weston |
Downgrades | Buy → Neutral | — |
| 2026-01-06 | Barclays |
Downgrades | Overweight → Equal-weight | — |
| 2025-12-09 | GuggenheimSeamus Fernandez |
Downgrades | Buy → Neutral | — |
| 2025-12-08 | JP MorganRichard Vosser |
Downgrades | Overweight → Neutral | — |
| 2025-10-27 | Jefferies |
Assumes | Buy | — |
| 2025-09-08 | Morgan StanleyMark Purcell |
Upgrades | Equal-weight → Overweight | $56 → $58 |
| 2025-09-02 | Deutsche BankEmmanuel Papadakis |
Upgrades | Hold → Buy | — |
| 2025-08-08 | JP MorganRichard Vosser |
Upgrades | Neutral → Overweight | — |
| 2025-03-21 | Goldman SachsJames Quigley |
Initiates coverage on | Neutral | $65 |
| 2024-07-26 | Argus ResearchJasper Hellweg |
Maintains | Buy | $55 → $60 |
| 2024-01-23 | Morgan StanleyMark Purcell |
Initiates coverage on | Equal-weight | $55 |
| 2023-03-27 | Argus ResearchJasper Hellweg |
Maintains | Buy | $55 → $60 |
| 2022-08-12 | Deutsche BankEmmanuel Papadakis |
Upgrades | Sell → Hold | — |
| 2021-09-27 | SVB LeerinkGeoffrey Porges |
Upgrades | Market perform → Outperform | — |
| 2021-01-15 | Deutsche BankEmmanuel Papadakis |
Initiates coverage on | Sell | — |
| 2020-03-11 | Goldman SachsKeyur Parekh |
Upgrades | Neutral → Buy | — |
| 2020-02-19 | Argus ResearchStephen Biggar |
Maintains | Buy | $52 → $56 |
| 2020-02-11 | SVB LeerinkGeoffrey Porges |
Initiates coverage on | Market perform | — |
| 2020-01-06 | JP MorganRichard Vosser |
Upgrades | Neutral → Overweight | — |
| 2019-12-06 | Barclays |
Downgrades | Equal-weight → Underweight | — |
| 2019-09-23 | Guggenheim |
Upgrades | Neutral → Buy | — |
| 2019-09-03 | Bernstein |
Initiates coverage on | Outperform | $52 |
| 2018-12-14 | Morgan Stanley |
Initiates coverage on | Equal-weight | — |
| 2018-11-08 | Argus ResearchStephen Biggar |
Maintains | Buy | $48 → $50 |
| 2018-11-01 | BarclaysEmmanuel Papada |
Upgrades | Underweight → Equal-weight | — |
| 2018-09-10 | B of A Securities |
Upgrades | Neutral → Buy | — |
| 2018-08-24 | Argus ResearchStephen Biggar |
Maintains | Buy | $46 → $48 |
| 2018-08-10 | Citigroup |
Upgrades | Neutral → Buy | — |
| 2018-01-23 | BarclaysMichael Leuchten |
Downgrades | Equal-weight → Underweight | — |
| 2017-11-15 | BarclaysEmmanuel Papada |
Upgrades | Underweight → Equal-weight | — |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $40.62
- Market Cap
- $98.67 billion
- 52-Week Range
- $40.55 – $52.68
- Average Volume
- 2.27 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.